• Markets
    • icon
  • Companies
MVP · ASX

Medical Developments International Limited (ASX:MVP)

AU$0.48

 0.0 (0.0%)
ASX:Live
25/07/2024 12:00:00 AM
HALO Ords HALO Consensus Value GROWTH AUS All-Consensus All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

MVP Overview

MVP Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Weak

Earnings

Neutral

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About MVP

Website

Medical Developments International Limited

Telephone

61.3.9547.1888

Address

Factory 6 4 Caribbean Drive Scoresby, Victoria (VIC) 3179

Description

Medical Developments International Ltd. engages in the manufacture and distribution of pharmaceutical drugs, medical, and veterinary equipment. It operates through the following segments: Pharmaceuticals, Medical Equipment, and Veterinary Equipment. The Pharmaceuticals segment involves the selling of Penthrox drugs. The Medical Equipment segment includes the sale of medical devices. The Veterinary Equipment segment relates to the sale of veterinary products within Australia, Europe, and Asia. The company was founded in 1971 and is headquartered in Scoresby, Australia.

MVP Price Chart

Key Stats

Market Cap

AU$41.86M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

100%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.38 - 1.27

Trade Value (12mth)

AU$22,501.00

1 week

-1.02%

1 month

19.75%

YTD

-46.7%

1 year

-59.58%

All time high

11.59

Key Fundamentals

EPS 3 yr Growth

-1268.400%

EBITDA Margin

-53.10%

Operating Cashflow

-$16m

Free Cash Flow Return

-23.00%

ROIC

-7.80%

Interest Coverage

-180.60

Quick Ratio

2.20

Other Data

Shares on Issue (Fully Dilluted)

86m

HALO Sector

Healthcare

Next Company Report Date

26-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.11

MVP Announcements

Latest Announcements

Date Announcements

26 July 24

Trading Halt

×

Trading Halt

12 July 24

FY24 Asset Review and Non-cash Write-downs

×

FY24 Asset Review and Non-cash Write-downs

30 April 24

Recording of 3Q24 Quarterly Report Investor Presentation

×

Recording of 3Q24 Quarterly Report Investor Presentation

29 April 24

Appendix 4C & Quarterly Activity Report - 31 March 2024

×

Appendix 4C & Quarterly Activity Report - 31 March 2024

29 April 24

Quarterly Report Webcast Details 3Q24

×

Quarterly Report Webcast Details 3Q24

29 April 24

Quarterly Report Investor Presentation

×

Quarterly Report Investor Presentation

15 April 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

15 March 24

Change in substantial holding

×

Change in substantial holding

29 February 24

2024 Half Year Report (including Appendix 4D)

×

2024 Half Year Report (including Appendix 4D)

29 February 24

2024 Half Year Presentation

×

2024 Half Year Presentation

29 February 24

2024 Half Year Announcement

×

2024 Half Year Announcement

28 February 24

FY24 Half Year Results Announcement Details

×

FY24 Half Year Results Announcement Details

24 January 24

Change in substantial holding

×

Change in substantial holding

28 November 23

Notification of cessation of securities - MVP

×

Notification of cessation of securities - MVP

28 November 23

Notification regarding unquoted securities - MVP

×

Notification regarding unquoted securities - MVP

31 October 23

2023 Annual General Meeting Recording

×

2023 Annual General Meeting Recording

27 October 23

2023 Annual General Meeting Presentation

×

2023 Annual General Meeting Presentation

27 October 23

2023 Annual General Meeting Chair and CEO address

×

2023 Annual General Meeting Chair and CEO address

27 October 23

Results of Annual General Meeting

×

Results of Annual General Meeting

25 September 23

Corporate Governance Statement

×

Corporate Governance Statement

25 September 23

Appendix 4G

×

Appendix 4G

25 September 23

Annual Report to Shareholders

×

Annual Report to Shareholders

25 September 23

Notice of Annual General Meeting and Proxy Form

×

Notice of Annual General Meeting and Proxy Form

11 September 23

Change of Director Interests

×

Change of Director Interests

11 September 23

Date of AGM and Closing Date for Director Nominations

×

Date of AGM and Closing Date for Director Nominations

MVP Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.18 -0.17 -0.07 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.18 -0.17 -0.07 Lock Lock Lock
     Growth % Lock Lock Lock Lock -3,268.4 5.1 61.1 Lock Lock Lock
     PE X Lock Lock Lock Lock 0.0 0.0 N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock 0.0 0.0 N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock 0.02 -0.13 -0.16 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.14 -0.16 -0.22 Lock Lock Lock
     Growth % Lock Lock Lock Lock 25.8 -978.4 -20.2 Lock Lock Lock
     Yield % Lock Lock Lock Lock -3.3 -11.5 -28.0 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock -100.0 N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock 0.5 1.0 N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.94 0.79 0.94 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.83 0.68 0.84 Lock Lock Lock
     Growth % Lock Lock Lock Lock 103.5 -18.0 24.0 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 70 72 84 Lock Lock Lock
Basic m Lock Lock Lock Lock 70 72 84 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 25 22 32 Lock Lock Lock
     Growth % Lock Lock Lock Lock 12.1 -11.5 44.6 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 22 13 18 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 17 -3 -3 Lock Lock Lock
     Growth % Lock Lock Lock Lock 21.4 -115.8 4.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock 66.0 -11.8 -7.8 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 34 112 108 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -1 -12 -17 Lock Lock Lock
     Growth % Lock Lock Lock Lock -133.3 -727.1 -39.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -5.9 -55.1 -53.1 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 4 3 3 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -5 -15 -20 Lock Lock Lock
     Growth % Lock Lock Lock Lock -379.7 -191.4 -32.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -20.7 -68.3 -62.7 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -15 -16 -7 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -2 -4 -2 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -13 -12 -6 Lock Lock Lock
     Growth % Lock Lock Lock Lock -3,415.3 1.3 54.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -49.7 -55.5 -17.3 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -9 -11 -16 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 7 5 8 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -7 -5 -8 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 36 0 28 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -10 -12 -18 Lock Lock Lock
     Growth % Lock Lock Lock Lock -1,028.5 -18.6 -53.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -0.4 -0.5 -0.6 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 36 20 25 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 100 101 109 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 3 2 2 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -33 -18 -22 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 32 44 28 Lock Lock Lock
Equity $m Lock Lock Lock Lock 68 57 81 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 71 60 84 Lock Lock Lock
     Growth % Lock Lock Lock Lock 53.5 -15.8 39.8 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -12.5 -12.2 -5.1 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -18.4 -21.7 -6.9 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -8.9 -23.2 -28.2 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -21.4 -19.0 -7.8 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -15.0 -16.4 -23.0 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock -12.3 -119.7 -180.6 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 22.3 1.4 1.3 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -48.6 -30.7 -27.2 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 6.8 3.3 2.8 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 6.0 2.6 2.2 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 76.6 59.3 57.7 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -126.6 -102.3 -106.1 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 5.6 4.0 4.3 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 1.5 3.9 4.5 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.6 0.9 1.2 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 13.1 23.1 41.2 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.3 0.2 0.3 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.3 0.2 0.3 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -59.3 -71.1 -23.2 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -15.0 -15.7 -6.8 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -12.5 -12.2 -5.1 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.5 1.8 1.3 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -18.4 -21.7 -6.9 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -18.4 -21.7 -6.9 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 246.4 93.7 81.1 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 65.7 91.6 85.7 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 312.1 185.3 166.7 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 154.4 58.6 93.4 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 157.8 126.7 73.3 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

100%

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.11%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

-0.10%

3 Month Change

-0.20%

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

MVP Shortsell

Frequently Asked Questions

The current share price of Medical Developments International Limited (MVP:ASX) is AU$0.48.
The 52-week high share price for Medical Developments International Limited (MVP:ASX) is AU$1.27.
The 52-week low share price for Medical Developments International Limited (MVP:ASX)? is AU$0.38.
Medical Developments International Limited (MVP:ASX) does not pay a dividend.
The last dividend payment of Medical Developments International Limited (MVP:ASX) is AU$0.02.
Medical Developments International Limited (MVP:ASX) has a franking level of 100.0%.
Medical Developments International Limited (MVP:ASX) is classified in the Healthcare.
The current P/E ratio for Medical Developments International Limited (MVP:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.